Danna Jennings

9.7k total citations
81 papers, 3.2k citations indexed

About

Danna Jennings is a scholar working on Neurology, Cellular and Molecular Neuroscience and Molecular Biology. According to data from OpenAlex, Danna Jennings has authored 81 papers receiving a total of 3.2k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Neurology, 19 papers in Cellular and Molecular Neuroscience and 15 papers in Molecular Biology. Recurrent topics in Danna Jennings's work include Parkinson's Disease Mechanisms and Treatments (42 papers), Neurological disorders and treatments (37 papers) and Botulinum Toxin and Related Neurological Disorders (9 papers). Danna Jennings is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (42 papers), Neurological disorders and treatments (37 papers) and Botulinum Toxin and Related Neurological Disorders (9 papers). Danna Jennings collaborates with scholars based in United States, Canada and Switzerland. Danna Jennings's co-authors include Kenneth Marek, John Seibyl, Shirley Eberly, Andrew Siderowf, David Oakes, Gilles Tamagnan, Mark A. Mintun, Michael J. Pontecorvo, Anupa Arora and Abhinay D. Joshi and has published in prestigious journals such as NeuroImage, Brain and Neurology.

In The Last Decade

Danna Jennings

79 papers receiving 3.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Danna Jennings United States 33 1.8k 738 720 584 490 81 3.2k
Hitoshi Shinotoh Japan 31 1.4k 0.8× 878 1.2× 1.0k 1.4× 681 1.2× 490 1.0× 109 3.4k
Hiroshige Fujishiro Japan 31 2.0k 1.1× 1.1k 1.4× 570 0.8× 724 1.2× 313 0.6× 114 3.2k
Nicola Tambasco Italy 25 1.9k 1.0× 749 1.0× 643 0.9× 347 0.6× 358 0.7× 85 2.7k
Kathrin Brockmann Germany 33 2.1k 1.2× 1.0k 1.4× 565 0.8× 340 0.6× 608 1.2× 125 3.2k
Laura Parkkinen United Kingdom 26 3.1k 1.7× 1.9k 2.6× 1.0k 1.4× 691 1.2× 712 1.5× 47 4.4k
Miho Murata Japan 37 2.4k 1.3× 698 0.9× 1.6k 2.2× 371 0.6× 1.4k 2.9× 164 4.8k
M. R. Luquín Spain 38 2.6k 1.5× 369 0.5× 1.9k 2.6× 278 0.5× 566 1.2× 148 4.0k
Albert Lladó Spain 34 1.6k 0.9× 1.8k 2.5× 433 0.6× 1.3k 2.1× 962 2.0× 132 4.3k
Caroline Moreau France 37 2.4k 1.3× 564 0.8× 636 0.9× 367 0.6× 1.1k 2.3× 113 4.5k
Chuantao Zuo China 30 1.3k 0.7× 621 0.8× 483 0.7× 382 0.7× 277 0.6× 164 2.6k

Countries citing papers authored by Danna Jennings

Since Specialization
Citations

This map shows the geographic impact of Danna Jennings's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Danna Jennings with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Danna Jennings more than expected).

Fields of papers citing papers by Danna Jennings

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Danna Jennings. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Danna Jennings. The network helps show where Danna Jennings may publish in the future.

Co-authorship network of co-authors of Danna Jennings

This figure shows the co-authorship network connecting the top 25 collaborators of Danna Jennings. A scholar is included among the top collaborators of Danna Jennings based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Danna Jennings. Danna Jennings is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Marek, Kenneth, David Russell, Luis Concha‐Marambio, et al.. (2025). Evidence for alpha-synuclein aggregation in older individuals with hyposmia: a cross-sectional study. EBioMedicine. 112. 105567–105567. 4 indexed citations
2.
Brašić, James Robert, Ayon Nandi, David Russell, et al.. (2020). Reduced Expression of Cerebral Metabotropic Glutamate Receptor Subtype 5 in Men with Fragile X Syndrome. Brain Sciences. 10(12). 899–899. 12 indexed citations
3.
Chahine, Lana M., Thomas G. Beach, Chelsea Caspell‐Garcia, et al.. (2018). Feasibility and Safety of Multicenter Tissue and Biofluid Sampling for α-Synuclein in Parkinson’s Disease: The Systemic Synuclein Sampling Study (S4). Journal of Parkinson s Disease. 8(4). 517–527. 15 indexed citations
4.
Jennings, Danna, Andrew Siderowf, Matthew Stern, et al.. (2017). Conversion to Parkinson Disease in the PARS Hyposmic and Dopamine Transporter–Deficit Prodromal Cohort. JAMA Neurology. 74(8). 933–933. 116 indexed citations
5.
Simuni, Tanya, Chelsea Caspell‐Garcia, Christopher S. Coffey, et al.. (2017). Baseline prevalence and longitudinal evolution of non-motor symptoms in early Parkinson’s disease: the PPMI cohort. Journal of Neurology Neurosurgery & Psychiatry. 89(1). 78–88. 72 indexed citations
6.
7.
Seibyl, John, Danna Jennings, & Kenneth Marek. (2015). Assessment of Parkinson disease progression using 123- I I-Ioflupane SPECT: Update from the Parkinson Progression Marker Initiative Trial (I11-5C). Neurology. 84(14_supplement). 1 indexed citations
8.
Okumura, Yuki, Ryohei Kobayashi, Yoshinari Shoyama, et al.. (2015). Preclinical properties and humanin vivoassessment of123I-ABC577 as a novel SPECT agent for imaging amyloid-β. Brain. 139(1). 193–203. 33 indexed citations
9.
Jennings, Danna, John Seibyl, Marwan N. Sabbagh, et al.. (2015). Age dependence of brain β-amyloid deposition in Down syndrome. Neurology. 84(5). 500–507. 48 indexed citations
10.
Okumura, Yuki, Yoshinari Shoyama, Olivier Barret, et al.. (2014). P4‐301: PRECLINICAL AND CLINICAL PROPERTIES OF [123I]ABC577: A NOVEL RADIOIODINATED SPECT AGENT FOR IMAGING B‐AMYLOID IN THE BRAIN. Alzheimer s & Dementia. 10(4S_Part_15).
11.
Tamagnan, Gilles, Adriana Tavares, Olivier Barret, et al.. (2012). Brain distribution of BZM055, an analog of fingolimod (FTY720), in human. Multiple Sclerosis Journal. 18. 379–379. 10 indexed citations
12.
Joshi, Abhinay D., Michael J. Pontecorvo, Alan Carpenter, et al.. (2012). Performance Characteristics of Amyloid PET with Florbetapir F 18 in Patients with Alzheimer's Disease and Cognitively Normal Subjects. Journal of Nuclear Medicine. 53(3). 378–384. 301 indexed citations
13.
Barret, Olivier, David Thomae, David Alagille, et al.. (2012). First in vivo assessment of two PDE10 tracers [18F]MNI654 and [18F]MNI659. 53(1). 361–361. 9 indexed citations
14.
Siderowf, Andrew, Danna Jennings, Shirley Eberly, et al.. (2012). Impaired olfaction and other prodromal features in the Parkinson At‐Risk Syndrome study. Movement Disorders. 27(3). 406–412. 144 indexed citations
15.
Seibyl, John, David Russell, Danna Jennings, & Kenneth Marek. (2012). Neuroimaging Over the Course of Parkinson's Disease: From Early Detection of the At-Risk Patient to Improving Pharmacotherapy of Later-Stage Disease. Seminars in Nuclear Medicine. 42(6). 406–414. 17 indexed citations
16.
Seibyl, John, I. George Zubal, Danna Jennings, Kenneth Marek, & P. Murali Doraiswamy. (2011). Molecular PET imaging in multicenter Alzheimer’s therapeutic trials: current trends and implementation strategies. Expert Review of Neurotherapeutics. 11(12). 1783–1793. 4 indexed citations
17.
Marek, Kenneth, Danna Jennings, & John Seibyl. (2003). Dopamine agonists and Parkinson's disease progression: What can we learn from neuroimaging studies. Annals of Neurology. 53(S3). S160–S169. 23 indexed citations
18.
Factor, Stewart A., Danna Jennings, Eric Molho, & Kenneth Marek. (2002). The Natural History of the Syndrome of Primary Progressive Freezing Gait. Archives of Neurology. 59(11). 1778–1778. 61 indexed citations
19.
Nygaard, Torbjoern G., Deborah Raymond, Caiping Chen, et al.. (1999). Localization of a gene for myoclonus-dystonia to chromosome 7q21-q31. Annals of Neurology. 46(5). 794–798. 71 indexed citations
20.
Jennings, Danna. (1995). Introduction to Medical Electronics Applications. Elsevier eBooks. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hitoshi Shinotoh Breakdown of academic impact, for papers by Hiroshige Fujishiro Breakdown of academic impact, for papers by Nicola Tambasco Breakdown of academic impact, for papers by Kathrin Brockmann Breakdown of academic impact, for papers by Laura Parkkinen Breakdown of academic impact, for papers by Miho Murata Breakdown of academic impact, for papers by M. R. Luquín Breakdown of academic impact, for papers by Albert Lladó Breakdown of academic impact, for papers by Caroline Moreau Breakdown of academic impact, for papers by Chuantao Zuo
Rankless by CCL
2026